Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103790912 | 10379091 | 2 | F | 201310 | 20160620 | 20140812 | 20160630 | EXP | US-GLAXOSMITHKLINE-A1083873A | GLAXOSMITHKLINE | 71.69 | YR | F | Y | 0.00000 | 20160630 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103790912 | 10379091 | 1 | PS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 250/50 | UNKNOWN | 21077 | 1 | DF | INHALATION POWDER | BID | |||||
| 103790912 | 10379091 | 2 | SS | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 1 PUFF(S), 1D | R658029 | 0 | 1 | DF | INHALATION POWDER | QD | |||||
| 103790912 | 10379091 | 3 | SS | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | 1 PUFF(S), 1D | R713285 | 0 | 1 | DF | INHALATION POWDER | QD | ||||||
| 103790912 | 10379091 | 4 | SS | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | UNK, 1D | R749798 | 0 | INHALATION POWDER | QD | |||||||
| 103790912 | 10379091 | 5 | SS | IPRATROPIUM BROMIDE + SALBUTAMOL SULPHATE | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | UNK | 5021 | 0 | |||||||||
| 103790912 | 10379091 | 6 | SS | PROAIR HFA | ALBUTEROL SULFATE | 1 | Unknown | 0 | |||||||||||
| 103790912 | 10379091 | 7 | SS | CPAP | DEVICE | 1 | Unknown | 0 | |||||||||||
| 103790912 | 10379091 | 8 | C | Calcium | CALCIUM | 1 | 0 | ||||||||||||
| 103790912 | 10379091 | 9 | C | Ipratropium | IPRATROPIUM | 1 | 0 | NEBULISER SOLUTION | |||||||||||
| 103790912 | 10379091 | 10 | C | PRAVASTATIN | PRAVASTATINPRAVASTATIN SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103790912 | 10379091 | 1 | Chronic obstructive pulmonary disease |
| 103790912 | 10379091 | 2 | Chronic obstructive pulmonary disease |
| 103790912 | 10379091 | 4 | Chronic obstructive pulmonary disease |
| 103790912 | 10379091 | 5 | Chronic obstructive pulmonary disease |
| 103790912 | 10379091 | 7 | Sleep apnoea syndrome |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103790912 | 10379091 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103790912 | 10379091 | Chest discomfort | |
| 103790912 | 10379091 | Cough | |
| 103790912 | 10379091 | Drug dose omission | |
| 103790912 | 10379091 | Drug ineffective | |
| 103790912 | 10379091 | Dyspnoea | |
| 103790912 | 10379091 | Eye haemorrhage | |
| 103790912 | 10379091 | Fungal infection | |
| 103790912 | 10379091 | Malaise | |
| 103790912 | 10379091 | Middle insomnia | |
| 103790912 | 10379091 | Pneumothorax | |
| 103790912 | 10379091 | Sleep apnoea syndrome | |
| 103790912 | 10379091 | Therapeutic response unexpected | |
| 103790912 | 10379091 | Unevaluable event | |
| 103790912 | 10379091 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103790912 | 10379091 | 1 | 2014 | 0 | ||
| 103790912 | 10379091 | 2 | 2014 | 201602 | 0 | |
| 103790912 | 10379091 | 4 | 201602 | 0 | ||
| 103790912 | 10379091 | 5 | 2007 | 0 |